Prince Pharmaceutical Co., Ltd. manufactures and sells vitamin B1 active pharmaceutical ingredients (APIs) in Taiwan, Japan, Korea, and internationally. The company also offers health food and medicines; vitamin C tablets, vitamin B film-coated tablets, natto and rhodiola extract capsules, probiotic sachets, and plant extract capsules; and API products comprising felbinac, aldioxa, tulobuterol, ufenamate, bisbentiamine, thiamine disulfide, potassium guaiacolsulfonate, potassium cresolsulfonate, fusultiamine hydrochloride, and fursultiamine. Prince Pharmaceutical Co., Ltd. was founded in 1962 …
Last updated
14 Aug 2026
Exchange
Taipei Exchange · TWO
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
TWD
Market capitalisation
1,090,501,504
Fair value reference
28.18
Next-week expectancy
Undecided · 50.25%
Executive chart read
Over the latest 12 completed weeks ending 2026-08-14, 6935 rose 2.95%, moving from 28.22 to 29.05. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 5 of the last 12 weeks. Relative Strength is -29.75 and has improved across the 12-week window. Market Dynamics is 0.34 on the latest week. Next-week expectancy is undecided at 50.25% based on similar historical setup states.
Week Ending
14 Aug 2026
Latest Close
29.05
12-Week Change
2.95%
Trend Signal
Active
Next-Week Expectancy
Undecided 50.25%
Signal Weeks
5 of 12
Weekly Price
Weekly Close
Trend Line
Fair Value
Activity Lines
Chart Panels
Choose up to 5 panels. Drag panel headers to reorder.
Price Action
Up Week
Down Week
Trend Line
Pivotal Level / Resistance
Volume
Range
Sharemaestro Range
Where price is trading
The fitted range, accepted trading area and strongest price levels are calculated automatically from completed weekly market data.
Current stateInside accepted value
52-week position
45.7%
Low to high
Accepted price
29.49
Latest versus accepted: -1.50%
Fitted direction
Sideways
0.01% per week
Range pressure
45/100
Balanced pressure
Range condition
Normal
1.22× normal range
Range pressureCurrent range pressure · 50 is balanced
Weekly closeFitted rangeActivity ribbonEstimated activity at priceAutomatic level
Automatic structure
Strongest price levels
Support26.17
From price
-9.9%
Evidence
50/100
Touches
2
Support27.97
From price
-3.7%
Evidence
72/100
Touches
8
Resistance29.49
From price
1.5%
Evidence
100/100
Touches
5
Resistance30.99
From price
6.7%
Evidence
80/100
Touches
6
Current reading
What the range shows
Current positionInside accepted value
Price is at 45.7% of its latest 52-week range.
Fitted directionSideways
The fitted centre line is moving +0.01% per week.
Range pressureBalanced pressure
The current pressure reading is 45/100; 50 is balanced.
Next structural level27.97
Support is 3.7% from the latest close with 72/100 evidence strength.
Point & Figure
Price structure · volume at price
Point & Figure market structure
Each X marks a rising price box and each O marks a falling price box. Time is removed from the horizontal scale so reversals, breakouts and areas of heavy trading stand out.
MethodAdaptive scale
Smart Money
Close Price
Trend Line
Demand Threshold Line
Reversal Risk Level
Market Dynamics
Volume Action
Price Action
Market Dynamics
Rate of Change
0-1.5TopBottomRawCloseMarket Strength30W ROCVolume SupportPrice Action RibbonBuyFlip UpFlip Down
Price Cycle
Market Price Cycle
PC Activity Line
PC Trend Line
Next-State Map
Next-State Map
Historical one-week transition paths from similar completed-week states.
SMI
Weekly Close
Trend Line
Fair Value
Activity Lines
SMI
Chart Summary
Key Points
Week Ending
14 Aug 2026
Latest Close
29.05
12-Week Change
2.95%
Trend Signal
Active
Next-Week Expectancy
Undecided 50.25%
Signal Weeks
5 of 12
Vs Trend Line
Below
Vs Fair Value
Above
Relative Strength
-29.75
Market Dynamics
0.34
Over the latest 12 completed weeks ending 2026-08-14, 6935 rose 2.95%, moving from 28.22 to 29.05. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 5 of the last 12 weeks. Relative Strength is -29.75 and has improved across the 12-week window. Market Dynamics is 0.34 on the latest week. Next-week expectancy is undecided at 50.25% based on similar historical setup states.
Industry Peers
Taiwan equities in Drug Manufacturers - Specialty & Generic
Search by ticker symbol or company name and select a result to open its chart.
Sharemaestro
Send a message
Ask a question, report a correction, or send a publisher/support note.
Cookie preferences
Essential cookies keep Sharemaestro secure and working. Choose whether we may use optional persistent analytics and advertising technologies. Limited cookieless server measurement continues for aggregate traffic and security.
